• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Combined antiplatelet therapy and oral anticoagulation: is a balance between thromboembolism and bleeding possible?

作者信息

Kuzniatsova Nadzeya, Lip Gregory Y H

出版信息

Int J Cardiol. 2011 Apr 1;148(1):1-3. doi: 10.1016/j.ijcard.2010.12.098. Epub 2011 Jan 17.

DOI:10.1016/j.ijcard.2010.12.098
PMID:21247646
Abstract
摘要

相似文献

1
Combined antiplatelet therapy and oral anticoagulation: is a balance between thromboembolism and bleeding possible?联合抗血小板治疗与口服抗凝治疗：能否实现血栓栓塞与出血之间的平衡？
Int J Cardiol. 2011 Apr 1;148(1):1-3. doi: 10.1016/j.ijcard.2010.12.098. Epub 2011 Jan 17.
2
[Warfarin combined with blood platelet inhibition].华法林联合血小板抑制
Tidsskr Nor Laegeforen. 2011 Feb 4;131(3):252-3. doi: 10.4045/tidsskr.09.1176.
3
Evaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta-analysis of observational studies.对有双重抗血小板治疗（DAPT）临床指征且需长期抗凝治疗的患者，使用或不使用华法林进行双重抗血小板治疗的疗效和安全性评估：一项观察性研究的荟萃分析
Catheter Cardiovasc Interv. 2016 Jul;88(1):E12-22. doi: 10.1002/ccd.26234. Epub 2015 Sep 10.
4
Efficacy and Safety of Triple Therapy and Dual Therapy With Direct Oral Anticoagulants Compared to Warfarin.与华法林相比，直接口服抗凝剂三联疗法和双联疗法的疗效与安全性
Int Heart J. 2017 Aug 3;58(4):570-576. doi: 10.1536/ihj.16-381. Epub 2017 Jul 13.
5
Dual antiplatelet therapy versus warfarin anticoagulation in patients undergoing catheter ablation of atrial fibrillation.房颤导管消融患者中双重抗血小板治疗与华法林抗凝治疗的比较
Int J Cardiol. 2014 May 1;173(2):345-6. doi: 10.1016/j.ijcard.2014.03.027. Epub 2014 Mar 15.
6
Optimal antithrombotic therapy in patients receiving long-term oral anticoagulation requiring percutaneous coronary intervention: "triple therapy" or "triple threat".接受长期口服抗凝治疗且需要经皮冠状动脉介入治疗的患者的最佳抗栓治疗：“三联疗法”还是“三重威胁”。
Chest. 2011 Feb;139(2):240-243. doi: 10.1378/chest.10-1102.
7
Efficacy of modified dual antiplatelet therapy combined with warfarin following percutaneous coronary intervention with drug-eluting stents.药物洗脱支架经皮冠状动脉介入术后改良双联抗血小板治疗联合华法林的疗效
J Invasive Cardiol. 2010 Feb;22(2):80-3.
8
Impact of anticoagulant therapy with dual antiplatelet therapy on prognosis after treatment with drug-eluting coronary stents.双联抗血小板治疗联合抗凝治疗对药物洗脱冠状动脉支架治疗后预后的影响。
J Cardiol. 2010 May;55(3):362-9. doi: 10.1016/j.jjcc.2009.12.014. Epub 2010 Feb 9.
9
Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation.华法林联合双联抗血小板治疗在有慢性口服抗凝指征的经皮冠状动脉介入治疗患者中的荟萃分析。
Int J Cardiol. 2011 Apr 1;148(1):96-101. doi: 10.1016/j.ijcard.2010.11.019. Epub 2010 Dec 23.
10
Twelve-month outcome of patients with an established indication for oral anticoagulation undergoing coronary artery stenting and stratified by the baseline risk of bleeding: Insights from the Warfarin and Coronary Stenting (War-Stent) Registry.接受冠状动脉支架置入术且有口服抗凝既定适应症的患者的12个月预后，并按基线出血风险分层：来自华法林与冠状动脉支架置入术（War-Stent）注册研究的见解
Cardiovasc Revasc Med. 2017 Sep;18(6):425-430. doi: 10.1016/j.carrev.2017.03.015. Epub 2017 Mar 19.

引用本文的文献

1
Anticoagulation therapy prevents portal-splenic vein thrombosis after splenectomy with gastroesophageal devascularization.抗凝治疗可预防贲门胃底血管离断术后脾切除术后门脾静脉血栓形成。
World J Gastroenterol. 2012 Jul 14;18(26):3443-50. doi: 10.3748/wjg.v18.i26.3443.